Wegovy pill approved by US FDA for weight loss

Wegovy becomes first pill of its kind to be approved, shifting weight-loss drugs beyond injections.

Watch LiveBritish Broadcasting CorporationHomeNewsSportBusinessInnovationCultureArtsTravelEarthAudioVideoLiveDocumentariesHomeNewsIsrael-Gaza WarWar in UkraineUS & CanadaUKUK PoliticsEnglandN. IrelandN. Ireland PoliticsScotlandScotland PoliticsWalesWales PoliticsAfricaAsiaChinaIndiaAustraliaEuropeLatin AmericaMiddle EastIn PicturesBBC InDepthBBC VerifySportBusinessExecutive LoungeTechnology of BusinessFuture of BusinessInnovationWatch DocumentariesTechnologyScience & HealthArtificial IntelligenceAI v the MindCultureWatch DocumentariesFilm & TVMusicArt & DesignStyleBooksEntertainment NewsArtsWatch DocumentariesArts in MotionTravelWatch DocumentariesDestinationsAfricaAntarcticaAsiaAustralia and PacificCaribbean & BermudaCentral AmericaEuropeMiddle EastNorth AmericaSouth AmericaWorld’s TableCulture & ExperiencesAdventuresThe SpeciaListEarthWatch DocumentariesNatural WondersWeather & ScienceClimate SolutionsSustainable BusinessGreen LivingAudioPodcast CategoriesRadioAudio FAQsVideoWatch DocumentariesBBC MaestroLiveLive NewsLive SportDocumentariesHomeNewsSportBusinessInnovationCultureArtsTravelEarthAudioVideoLiveDocumentariesWeatherNewslettersWatch LiveUS regulator approves pill form of Wegovy weight-loss drug14 hours agoShareSaveKwasi AsieduandOsmond ChiaShareSaveBloomberg via Getty ImagesThe US Food and Drug Administration (FDA) has approved a pill version of the weight-loss drug Wegovy, according to pharmaceutical giant Novo Nordisk.

It is the first pill of its kind to receive approval from the regulator, marking a new era for weight-loss drugs.

Wegovy's Danish makers Novo Nordisk said the once-daily pill was a "convenient option" to the injectable and would provide the same weight loss as the shot. It comes after Wegovy was approved by the FDA specifically for weight loss.

Others like Ozempic, which has similar weight-loss effects, were primarily approved for the treatment of Type 2 diabetes.

The BBC has contacted the FDA for comment.